OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Greg Walden, Hearing on Examining How Covered Entities Utilize the 340B Drug Pricing Program

Hearing

Date: Oct. 11, 2017
Location: Washington, DC
Issues: Government Operations Health and Health Care

Only available in PDF format; please see source to view document.


Source
arrow_upward